Stonehage Fleming (UK) Ltd - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
Stonehage Fleming (UK) Ltd ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2013$49,0002,0080.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders